Effect of Iron Deficiency Anemia on HbA1c in Diabetic Patients in Salah al-Din Hospital, Iraq

Main Article Content

Huda Ayad Hameed

Abstract

Hemoglobin A1C (HbA1c) is the main hemoglobin detected in HbA1 components. A1C test is the approved assay for assessing diabetes. Iron deficiency anemia (IDA), on the other hand, has been discovered to have an effect on HBA1C level; however, the effects are still being investigated.The present study was designed to examine the association between Iron Deficiency Anemia (IDA) and HbA1c in diabetic patients presenting at Salah al-Din Hospital, Iraq.


From September 2021 to August 2022, 120 diabetic patients (60 with IDA and 60 without IDA) were included in a healthcare comparative cross-sectional research. A structured questionnaire was used to gather sociodemographic information as well as clinical circumstances. Venous blood was obtained for hematological tests and HbA1c test. SPSS version 21 was used to analyse the data. Pearson's correlation, and the one sample t-test were computed. The information was reported as mean + SD. P-value of less than 0.05 was considered statistically significant.In the IDA group, mean hemoglobin (Hgb), Red Blood Cell count (RBC), HBA1C, hematocrit (HCT), mean cell volume (MCV), mean cell hemoglobin (MCHC) and mean cell hemoglobin (MCH) levels were lower than in the non-IDA diabetic individuals. HbA1c (%) levels were substantially lower in the IDA group (6.78 + 7.0) than in non-IDA diabetic individuals (7.04 + 0.46) with statistically significant p-value.


The level of HbA1c in patients of diabetic with IDA are considerably lower than in diabetic patients without IDA. As a result, it is suggested that only HBA1C screening in these patients may be deceptive, so the doctors and clinicians should consider this before making any treatment decisions. A thorough assessment with a large number of subjects using sophisticated laboratory methods is advised.


 

Article Details

Section
Articles